Universal Ibogaine Inc.-Focused on New Treatment for Opioid Addiction and Other Substances Going Public – Introductory Note

In this note we are introducing Universal Ibogaine Inc. (“UI”), a privately held company building an addiction treatment business. UI plans to file a Clinical Trial Application with Health Canada by mid 2021, as well as open ibogaine based psychotherapy centres in jurisdictions where ibogaine use is legal. The company is scheduled to go public through a reverse-takeover (“RTO”) transaction with a TSXV listed capital pool company. The transaction is expected to close in February 2021.

Read More